BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28964261)

  • 1. Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations.
    Menéndez R; Méndez R; Polverino E; Rosales-Mayor E; Amara-Elori I; Reyes S; Sahuquillo-Arce JM; Fernández-Barat L; Alcaraz V; Torres A
    BMC Infect Dis; 2017 Sep; 17(1):659. PubMed ID: 28964261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
    Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
    Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and outcomes of multidrug-resistant bacterial infection in non-cystic fibrosis bronchiectasis.
    Chang CH; Chang CH; Huang SH; Lee CS; Ko PC; Lin CY; Hsieh MH; Huang YT; Lin HC; Li LF; Chung FT; Wang CH; Huang HY
    Ann Clin Microbiol Antimicrob; 2024 Feb; 23(1):15. PubMed ID: 38350983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for drug-resistant pathogens in immunocompetent patients with pneumonia: Evaluation of PES pathogens.
    Ishida T; Ito A; Washio Y; Yamazaki A; Noyama M; Tokioka F; Arita M
    J Infect Chemother; 2017 Jan; 23(1):23-28. PubMed ID: 27729192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic-resistant
    Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():237-246. PubMed ID: 29386892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed risk factors for infection with multidrug-resistant pathogens in hemodialysis patients hospitalized with pneumonia.
    Song JU; Park HK; Kang HK; Lee J
    BMC Infect Dis; 2017 Oct; 17(1):681. PubMed ID: 29025395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
    McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A
    Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antibiotics for bronchiectasis.
    Felix LM; Grundy S; Milan SJ; Armstrong R; Harrison H; Lynes D; Spencer S
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012514. PubMed ID: 29889304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa.
    Cotton MF; Wasserman E; Smit J; Whitelaw A; Zar HJ
    BMC Infect Dis; 2008 Apr; 8():40. PubMed ID: 18380900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?
    Guillamet CV; Vazquez R; Noe J; Micek ST; Kollef MH
    Medicine (Baltimore); 2016 Aug; 95(35):e4708. PubMed ID: 27583907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
    Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
    J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital.
    Patro S; Sarangi G; Das P; Mahapatra A; Mohapatra D; Paty BP; Chayani N
    Indian J Pathol Microbiol; 2018; 61(3):375-379. PubMed ID: 30004058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prevalence and Significance of Staphylococcus aureus in Patients with Non-Cystic Fibrosis Bronchiectasis.
    Metersky ML; Aksamit TR; Barker A; Choate R; Daley CL; Daniels LA; DiMango A; Eden E; Griffith D; Johnson M; Knowles M; O'Donnell AE; Olivier K; Salathe M; Thomashow B; Tino G; Turino G; Winthrop KL; Mannino D
    Ann Am Thorac Soc; 2018 Mar; 15(3):365-370. PubMed ID: 29345970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis.
    Chalmers JD; Rother C; Salih W; Ewig S
    Clin Infect Dis; 2014 Feb; 58(3):330-9. PubMed ID: 24270053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Survey on the Management of Adult Bronchiectasis in Belgium.
    Schoovaerts K; Lorent N; Goeminne P; Aliberti S; Dupont L
    COPD; 2019 Feb; 16(1):72-74. PubMed ID: 30786778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
    Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J
    Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent prophylactic antibiotics for bronchiectasis.
    Spencer S; Donovan T; Chalmers JD; Mathioudakis AG; McDonnell MJ; Tsang A; Leadbetter P
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013254. PubMed ID: 34985761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional risk factors for infection by multidrug-resistant pathogens in healthcare-associated infection: a large cohort study.
    Cardoso T; Ribeiro O; Aragão IC; Costa-Pereira A; Sarmento AE
    BMC Infect Dis; 2012 Dec; 12():375. PubMed ID: 23267668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.